TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30554220

Group type: EXPERIMENTAL
Intervention: Mediterranean diet enhanced with extra virgin olive oil and pistachios (40-42% fats of total caloric intake)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Standard-care control group (30% of total caloric intake from fats)
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Mediterranean diet enhanced with extra virgin olive oil and pistachios
Number of subjects: 697
Study: 28346721

Group type: EXPERIMENTAL
Intervention: Dynamic lumbopelvic stabilization (DLS) exercises
Number of subjects: 33

Group type: COMPARATOR
Intervention: Exercises for pelvic floor muscles (PFM)
Number of subjects: 33
Study: 26010794

Group type: EXPERIMENTAL
Intervention: Isometric training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Active stiffness assessment
Number of subjects: 24
Study: 23547212

Group type: EXPERIMENTAL
Intervention: Early local joint swelling and tenderness (at least once, or for ≥ 2 consecutive visits) in the first 2 years
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Swelling without tenderness
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Persistent swelling and/or tenderness
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Baseline erythrocyte sedimentation rate
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Presence of rheumatoid factor
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Presence of anticitrullinated protein antibodies
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Large-joint damage
Number of subjects: 290
Study: 21570685

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg + ezetimibe 10 mg (S+E)
Number of subjects: 67

Group type: COMPARATOR
Intervention: simvastatin 40 mg (S)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg (E)
Number of subjects: 67
Study: 19352163

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 16765796

Group type: EXPERIMENTAL
Intervention: Vancomycin (20 microg/mL) and gentamicin (8 microg/mL) in the infusion fluid
Number of subjects: 41

Group type: COMPARATOR
Intervention: No antibiotics in the infusion fluid (control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with increased macular thickness on OCT
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with no change in macular thickness on OCT
Number of subjects: 41
Study: 15499292

Group type: EXPERIMENTAL
Intervention: MR techniques
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radionuclide studies (nor‐cholesterol)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radionuclide studies (MIBG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radionuclide studies (FDG)
Number of subjects: 30
Study: 11878735

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 40
Study: 11367660

Group type: EXPERIMENTAL
Intervention: Bushen Tiaogan Lianru Recipe (BTLR)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 72
Study: 8151047

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 84

Group type: COMPARATOR
Intervention: Clomipramine or Desipramine
Number of subjects: 84
Study: 3596865

Group type: EXPERIMENTAL
Intervention: Voltaren 25, Ciba‐Geigy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Anfenax 25, Istituto Biochimico Italiano
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ciba‐Geigy preparation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Istituto Biochimico Italiano preparation
Number of subjects: 8
Study: 29288510

Group type: EXPERIMENTAL
Intervention: Psychopharmacotherapy with nursing interventions for anxiety (Nursing Interventions Classification)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment-as-usual (psychopharmacotherapy only)
Number of subjects: 60
Study: 26592506

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 4873

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4873
Study: 24620855

Group type: EXPERIMENTAL
Intervention: Oral therapy with Repaglinide
Number of subjects: 74

Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 74
Study: 22700378

Group type: EXPERIMENTAL
Intervention: Improved household water infrastructure
Number of subjects: 0
Study: 21518046

Group type: EXPERIMENTAL
Intervention: RBC transfusion in MOF patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: RBC transfusion in patients developing MOF
Number of subjects: 29

Group type: COMPARATOR
Intervention: No RBC transfusion
Number of subjects: 29
Study: 18499566

Group type: EXPERIMENTAL
Intervention: Bivalirudin alone
Number of subjects: 3602

Group type: COMPARATOR
Intervention: Heparin plus glycoprotein IIb/IIIa inhibitors
Number of subjects: 3602
Study: 17024986

Group type: EXPERIMENTAL
Intervention: Advertisements in major Montreal newspapers
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Placement of ads in senior newspapers
Number of subjects: 2001
Study: 12704000

Group type: EXPERIMENTAL
Intervention: COAPC regimen combined with whole-brain radiotherapy (WBRT)
Number of subjects: 45
Study: 10948073

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Weight management combining aerobic exercise with a behavioral weight loss program
Number of subjects: 99
Study: 8833718

Group type: EXPERIMENTAL
Intervention: Eccentric-only dynamic constant external resistance (DCER) training of the leg extensor muscles (3-5 sets of 6 repetitions at 80% of the eccentric one-repetition maximum load) for eight weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Eccentric-only dynamic constant external resistance (DCER) training of the leg extensor muscles
Number of subjects: 17
Study: 1423946

Group type: EXPERIMENTAL
Intervention: Combined lower limbs and upper limbs (LL+UL) exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lower limbs (LL) exercise alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined LL+UL exercise
Number of subjects: 24
Study: 3532786

Group type: EXPERIMENTAL
Intervention: Auranofin (3 mg twice daily)
Number of subjects: 303
Study: 31935136

Group type: EXPERIMENTAL
Intervention: Self-mobilization plus CrossFit training
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CrossFit training alone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 30077184

Group type: EXPERIMENTAL
Intervention: Early treatment with ibuprofen (COXi) between 24 and 72 hours postnatal age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectative management (no intervention intended to close a PDA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early treatment with ibuprofen (COXi)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectative management
Number of subjects: 0
Study: 27093514

Group type: EXPERIMENTAL
Intervention: Early Feedback Group (EFG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Late Feedback Group (LFG)
Number of subjects: 18
Study: 24549548

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg per day titrated to 30 mg per day over 9 weeks)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 22954510

Group type: EXPERIMENTAL
Intervention: Naltrexone (50mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20886789

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with acupoint sticking therapy (AST)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Western medication (Mesalazine)
Number of subjects: 90
Study: 18426893

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 32
Study: 19951520

Group type: EXPERIMENTAL
Intervention: Nasal inhaled corticosteroid (ICS) through a spacer with mask (budesonide inhaler 400 microg/d)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Orally inhaled budesonide dry powder (400 microg/d) plus nasal spray of budesonide aquae (256 microg/d)
Number of subjects: 72
Study: 15364229

Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate ophthalmic suspension, 0.5%, 4 times a day for 4 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 64
Study: 11457700

Group type: EXPERIMENTAL
Intervention: Modified phenol chemical peels with varying concentrations of phenol and croton oil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standardized application technique
Number of subjects: 16
Study: 9190324

Group type: EXPERIMENTAL
Intervention: Tramadol 300mg/day (oral)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Buprenorphine 0.6mg/day (sublingual)
Number of subjects: 60
Study: 7955906

Group type: EXPERIMENTAL
Intervention: L-arginine infusion (30 g, 30 min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3117236

Group type: EXPERIMENTAL
Intervention: somatrem (methionyl growth hormone)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 30683140

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention to reduce re-hospitalization through patient activation
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Participants who agreed to the intervention
Number of subjects: 385
Study: 29871327

Group type: EXPERIMENTAL
Intervention: Posterior approach parotid gland region resection preserving retinal ganglion and parotid fascia
Number of subjects: 112

Group type: COMPARATOR
Intervention: Anterior approach parotid gland region resection preserving retinal ganglion and parotid fascia
Number of subjects: 112
Study: 26495319

Group type: EXPERIMENTAL
Intervention: Propofol (target-controlled infusion)
Number of subjects: 31
Study: 23090858

Group type: EXPERIMENTAL
Intervention: Educational animation explaining how EGMs work
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pop-up limit reminder
Number of subjects: 72

Group type: COMPARATOR
Intervention: Neutral video (control)
Number of subjects: 72
Study: 21338974

Group type: EXPERIMENTAL
Intervention: Nintendo Wii™ group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 19211665

Group type: EXPERIMENTAL
Intervention: Ramipril therapy for 12 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: After 12-week treatment
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Multivariate regression analysis
Number of subjects: 49
Study: 16952598

Group type: EXPERIMENTAL
Intervention: Frenotomy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 25
Study: 15552602

Group type: EXPERIMENTAL
Intervention: High-dose isotretinoin (13‐cis‐retinoic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11555064

Group type: EXPERIMENTAL
Intervention: Office-based recruitment strategy
Number of subjects: 188

Group type: COMPARATOR
Intervention: Roster-based recruitment strategy
Number of subjects: 188
Study: 9240534

Group type: EXPERIMENTAL
Intervention: Rapid MR imaging
Number of subjects: 62

Group type: COMPARATOR
Intervention: Plain radiography
Number of subjects: 62
Study: 8199827

Group type: EXPERIMENTAL
Intervention: Nilutamide plus orchidectomy
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1056
Study: 3475201

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg three times a day for eight days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo identical in appearance to ibuprofen
Number of subjects: 10
Study: 30150437

Group type: EXPERIMENTAL
Intervention: 1:1 metronome-paced breathing during cellular phone exposure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1:2 metronome-paced breathing during cellular phone exposure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-exposure effect
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 20
Study: 29798336

Group type: EXPERIMENTAL
Intervention: Radiotherapy and chemotherapy combined with cetuximab
Number of subjects: 78

Group type: COMPARATOR
Intervention: Radiotherapy and diamminedichloroplatinum
Number of subjects: 78
Study: 24471739

Group type: EXPERIMENTAL
Intervention: Convergence exercises independent of accommodation
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Accommodation exercises
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Combined convergence and accommodation exercises
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo regime
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group with maximum effort
Number of subjects: 156
Study: 22052231

Group type: EXPERIMENTAL
Intervention: Voluntary medical male circumcision (VMMC)
Number of subjects: 1344

Group type: EXPERIMENTAL
Intervention: Being married or cohabitating
Number of subjects: 1344
Study: 20122266

Group type: EXPERIMENTAL
Intervention: Training and support programme for general practice teams, including multidisciplinary training sessions, integration of prompts in electronic medical records, and a direct referral pathway to a domestic violence advocate.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified in detail in the abstract).
Number of subjects: 48
Study: 17941869

Group type: EXPERIMENTAL
Intervention: Diet alone, diet followed by metformin, or metformin alone
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1084
Study: 15852991

Group type: EXPERIMENTAL
Intervention: Melatonin 0.25 mg kg(‐1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Melatonin 0.5 mg kg(‐1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Midazolam 0.25 mg kg(‐1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg kg(‐1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 105

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (15 mg kg(‐1) acetaminophen)
Number of subjects: 105
Study: 12578251

Group type: EXPERIMENTAL
Intervention: Easy visual degradation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Medium visual degradation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Hard visual degradation
Number of subjects: 150
Study: 9524026

Group type: EXPERIMENTAL
Intervention: Phaco-emulsification with trabeculectomy (phaco-trab)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Extracapsular cataract extraction with trabeculectomy (ECCE-trab)
Number of subjects: 50
Study: 7621311

Group type: EXPERIMENTAL
Intervention: Exposure to conventional risk factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 0
Study: 2572137

Group type: EXPERIMENTAL
Intervention: Datex Relaxograph
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New bolus-constant infusion regimen of atracurium
Number of subjects: 0
Study: 5441886

Group type: EXPERIMENTAL
Intervention: Intravenous secretin (2 units per kilogram per hour)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrajejunal acid infusion
Number of subjects: 0
Study: 29695183

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 chewable tablets
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 27040087

Group type: EXPERIMENTAL
Intervention: Exercise Training (4-month cycloergometer training)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Testosterone (intramuscular injection of testosterone undecylate for 4 months)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Training + Testosterone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 39
Study: 24893955

Group type: EXPERIMENTAL
Intervention: Light and intermittent smokers
Number of subjects: 41

Group type: COMPARATOR
Intervention: Heavy smokers
Number of subjects: 41
Study: 22551058

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (n = 200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Delayed intervention group (n = 200)
Number of subjects: 400
Study: 20180173

Group type: EXPERIMENTAL
Intervention: Balance Training (BT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 20
Study: 18339788

Group type: COMPARATOR
Intervention: Neither primary caregiver nor day-care provider smoked
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Either primary caregiver or day-care provider smoked
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Both primary caregiver and day-care provider smoked
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Parental perception of child's exposure
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Parents reporting tobacco smoke exposure having small/no negative effect on child's asthma
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Parents contemplating, preparing, or recently taking action to reduce child's exposure
Number of subjects: 519
Study: 16019761

Group type: EXPERIMENTAL
Intervention: Statistical methods integrating molecular biomarkers with existing prognostic factors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current staging system
Number of subjects: 0
Study: 12752020

Group type: EXPERIMENTAL
Intervention: Non-melancholic depressed patients
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Comorbid personality disorder
Number of subjects: 210
Study: 11134978

Group type: EXPERIMENTAL
Intervention: Black currant anthocyanosides (BCA) 50 mg/subject
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Black currant anthocyanosides (BCA)
Number of subjects: 21
Study: 8916484

Group type: EXPERIMENTAL
Intervention: Treatment of lipid disorders after angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 1397814

Group type: EXPERIMENTAL
Intervention: Home visits focusing on smoking, drug and nutrition education, support, and links with community services
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (no home visits)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Intervention group (home visits)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Family function screen
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Revised equation involving history of previous premature birth, smoking, and low maternal weight-height ratio
Number of subjects: 154
Study: 4056250

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 17

Group type: COMPARATOR
Intervention: Propranolol (after histamine provocation)
Number of subjects: 17
Study: 30561509

Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD20+ T cells in CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD20+ T cells in blood
Number of subjects: 0
Study: 28217889

Group type: EXPERIMENTAL
Intervention: EBFT-home
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: EBFT-office
Number of subjects: 183

Group type: COMPARATOR
Intervention: Women's Health Education
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: EBFT (both home and office)
Number of subjects: 183
Study: 27555203

Group type: EXPERIMENTAL
Intervention: Single-level ultrasound-guided TPVB (group S)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Double-level ultrasound-guided TPVB (group D)
Number of subjects: 60
Study: 25322163

Group type: EXPERIMENTAL
Intervention: Lateral nail avulsion with phenolization (LNAP)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Sleeve (nail tube splinting) method
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 53
Study: 22056537

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Appendicular Lean Mass (aLM)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Muscle Power
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Self-reported functional deficits (SF-LLFDI)
Number of subjects: 69
Study: 20602712

Group type: EXPERIMENTAL
Intervention: Tapentadol ER (100 to 250 mg bid)
Number of subjects: 1117

Group type: COMPARATOR
Intervention: Oxycodone CR (20 to 50 mg bid)
Number of subjects: 1117
Study: 18047650

Group type: EXPERIMENTAL
Intervention: Manual therapy, exercise and advice with traction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual therapy, exercise and advice without traction
Number of subjects: 30
Study: 16037865

Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 139

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 139
Study: 11165735

Group type: EXPERIMENTAL
Intervention: Follicular fluid
Number of subjects: 23

Group type: COMPARATOR
Intervention: Blood
Number of subjects: 23
Study: 9330386

Group type: EXPERIMENTAL
Intervention: Extensive lymphadenectomy (n = 23)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Conventional lymphadenectomy (n = 22)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Curative operation (RO)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Non-curative operation (R1 and R2)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Overall operative death rate
Number of subjects: 248
Study: 7892983

Group type: EXPERIMENTAL
Intervention: Oxygen therapy for 24 hours followed by continuation for 3 days (Group 1)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Oxygen therapy for 3 days (Group 3)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Discontinued oxygen after Day 1 (Group 2)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No oxygen therapy (Group 4)
Number of subjects: 83